Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRADA-CEF trial: stratified ceftriaxone dosing in severe community-acquired pneumonia
2022-502013-28-00Phase 4Authorised
- Sponsor
- UZ Leuven
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ceftriaxone in community-acquired pneumonia (CAP), sponsored by UZ Leuven. Primary endpoint: Intensive care unit length of stay. Planned start Dec 2023; status: authorised.
02
Drugs
ceftriaxone
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2022-502013-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502013-28-00.